Australia is eagerly anticipating the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a significant advance in obesity treatment . Early study data have demonstrated https://giantlivbike312948.ouyawiki.com/2668061/emerging_medication_in_australia_a_promising_hope_for_weight_loss